The U.S. Food and Drug Administration (FDA) in December issued a safety alert urging people with diabetes to stop using select glucose sensors made by Abbott Laboratories’ (NYSE:ABT) Diabetes Care, after the company linked the devices to seven deaths and…
On Thursday, the U.S. Food and Drug Administration (FDA) approved Bristol Myers Squibb & Co.’s (NYSE:BMY) Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for adult patients with relapsed or refractory (R/R) marginal zone lymphoma…
Praxis Precision Medicines Inc. (NASDAQ:PRAX) shares surged 24.81% in pre-market trading on Friday, climbing to $237.10. Check out the current price of PRAX stock here. PRAX closed Thursday's regular session at $189.97, up 2.05%, according to Benzinga Pro data. Early…
Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher on Thursday. The clinical-stage biopharmaceutical company seems to be benefitting from wider excitement in the obesity treatment area, as well as recent positive momentum after major clinical trial developments. VKTX stock is…
Eli Lilly and Company (NYSE:LLY) shares are in the spotlight following reports indicating the company is close to finalizing a White House agreement to provide its lowest-dose obesity medications at $149 per month, which could open the door to Medicare…
Johnson & Johnson (NYSE:JNJ) is reportedly in discussions to acquire Protagonist Therapeutics (NASDAQ:PTGX). Citing people close to the talks, the Wall Street Journal reported that the deal is not guaranteed, and the terms have yet to be finalized. Year to…
Opendoor Technologies Inc (NASDAQ:OPEN) shares are falling on Monday after hedge fund manager George Noble posted on X that the company is “total garbage,” raising concerns about the stock’s recent rally. What Happened: Noble, who has founded two billion-dollar hedge…
Market speculation is mounting on a potential tie-up between QuantumScape Corp. (NYSE:QS) and Tesla, Inc. (NASDAQ:TSLA). While no official announcement has been made, there are some notable links between the battery maker and the EV giant. Here's a look at…
Corteva Inc. (NYSE:CTVA) is reportedly considering a major restructuring that would split its seed and pesticide operations into two separate entities. The pure-play agriculture company, valued at roughly $50 billion, could announce its plans soon if negotiations stay on track.…
New On The Block Siemens Healthineers is chatting with major private equity firms about a potential sale of its diagnostics business. According to Bloomberg, Blackstone, CVC, KKR, and Montagu are interested. The segment is valued at over €6 billion ($7…